Anti‐inflammatory and antiobesity effects of carvacrol derivatives (CD1‐3) were investigated in vitro (3T3‐L1, WJ‐MSCs, and THP‐1 cell lines) by assessing the expression of obesity‐related proteins and reducing TNF‐α expression, respectively. Here, ANPEP is linked to Obesity.